Search research articles
Contact Us
Filters
Showing results (11-20 of 565) with videos related to
Page
of 57
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2016
Implications of Blood-Based T790M Genotyping and Beyond in Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer
Rafael Rosell, Niki Karachaliou
Drugs of Today (Barcelona, Spain : 1998)
|
April 22, 2006
Clinical experience with erlotinib in non-small-cell lung cancer
Enriqueta Felip, Rafael Rosell
Nature Reviews. Clinical Oncology
|
August 21, 2013
Lung cancer: Maintenance therapy and precision medicine in NSCLC
Rafael Rosell, Niki Karachaliou
Ebiomedicine
|
April 9, 2019
Disulfide isomerase family-6 mediates cisplatin resistance by interfering with apoptosis and autophagy
Rafael Rosell, Niki Karachaliou
Seminars in Oncology
|
May 23, 2002
Pemetrexed combination therapy in the treatment of non-small cell lung cancer
Rafael Rosell, Lucio Crinó
Cancer Biology & Medicine
|
July 16, 2015
PD-L1 expression associated with better response to EGFR tyrosine kinase inhibitors
Rafael Rosell, Ramón Palmero
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 15, 2013
Optimal detection of ALK rearranged lung adenocarcinomas
Niki Karachaliou, Rafael Rosell
Future Oncology (London, England)
|
August 2, 2013
Small-cell lung cancer: where are we now and what can we expect for the future?
Niki Karachaliou, Rafael Rosell
Therapeutics and Clinical Risk Management
|
October 2, 2008
Pemetrexed as second-line therapy for advanced non-small-cell lung cancer (NSCLC)
Enriqueta Felip, Rafael Rosell
The Lancet. Respiratory Medicine
|
July 24, 2017
Brain metastases in patients with EGFR-mutant non-small-cell lung cancer
Rafael Rosell, Niki Karachaliou
Page
of 57
Search research articles
Search
Showing results (11-20 of 565) with videos related to
Sort By:
Page
of 57
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2016
Implications of Blood-Based T790M Genotyping and Beyond in Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer
Rafael Rosell, Niki Karachaliou
Drugs of Today (Barcelona, Spain : 1998)
|
April 22, 2006
Clinical experience with erlotinib in non-small-cell lung cancer
Enriqueta Felip, Rafael Rosell
Nature Reviews. Clinical Oncology
|
August 21, 2013
Lung cancer: Maintenance therapy and precision medicine in NSCLC
Rafael Rosell, Niki Karachaliou
Ebiomedicine
|
April 9, 2019
Disulfide isomerase family-6 mediates cisplatin resistance by interfering with apoptosis and autophagy
Rafael Rosell, Niki Karachaliou
Seminars in Oncology
|
May 23, 2002
Pemetrexed combination therapy in the treatment of non-small cell lung cancer
Rafael Rosell, Lucio Crinó
Cancer Biology & Medicine
|
July 16, 2015
PD-L1 expression associated with better response to EGFR tyrosine kinase inhibitors
Rafael Rosell, Ramón Palmero
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 15, 2013
Optimal detection of ALK rearranged lung adenocarcinomas
Niki Karachaliou, Rafael Rosell
Future Oncology (London, England)
|
August 2, 2013
Small-cell lung cancer: where are we now and what can we expect for the future?
Niki Karachaliou, Rafael Rosell
Therapeutics and Clinical Risk Management
|
October 2, 2008
Pemetrexed as second-line therapy for advanced non-small-cell lung cancer (NSCLC)
Enriqueta Felip, Rafael Rosell
The Lancet. Respiratory Medicine
|
July 24, 2017
Brain metastases in patients with EGFR-mutant non-small-cell lung cancer
Rafael Rosell, Niki Karachaliou
Page
of 57